Skip to main content

Hapto therapy

Version: 19-09-2026

What is the intervention? 

Haptotherapy is the therapeutic application of haptonomy. It is a distinct approach with virtually no post-COVID literature; it focuses on body awareness, touch, contact, and the recognition of physical and emotional signals. Treatment by a haptotherapist can be used for, for example, tension, difficulty with body boundaries, or learning to perceive signals of strain. No controlled clinical studies were found for haptonomy as a treatment for post-COVID, QVS, chronic Q fever, or complaints following vaccination. Therefore, this intervention must be distinguished from evidence-based physiotherapeutic or respiratory rehabilitation.

What is known about the mechanism of action of the intervention? 

For haptotherapy, effects are hypothesized through body awareness, relaxation, boundary recognition, and therapeutic interaction. These explanations are primarily conceptual. There is no sufficiently substantiated biological mechanism of action demonstrating an effect on the underlying pathophysiology of PAIS.

What is known about the effect? 

Post-COVID 

No randomized or other convincing clinical studies were found regarding haptotherapy as a treatment for post-COVID. Various non-pharmacological therapies tried by patients are mentioned in Dutch knowledge reviews, but research into the effectiveness and safety of such therapies is limited or absent. Haptonomy can therefore be considered, at most, as supplementary, person-centered support when a patient personally benefits from it. There is no evidence that it treats the underlying disease processes of post-COVID.

Q fever fatigue syndrome (QFS) 

There is no direct clinical evidence for haptonomy at QVS. The lack of research does not automatically mean that haptonomy cannot help, but just as with post-COVID, it can at most be considered supplementary, person-centered support.

Chronic Q fever 

Chronic Q fever is a persistent infection with Coxiella burnetii, often involving heart valves or blood vessels, and requires specialist medical treatment. No evidence has been found for haptonomy as a specific treatment for chronic Q fever. The lack of research does not automatically mean that haptonomy cannot help, but just as with post-COVID, it can at most be considered supplementary, person-centered support.

Complaints after vaccination 

There is hardly any intervention research specifically investigating haptonomy for long-term complaints following COVID-19 vaccination (KNV). No clinical studies were found for haptonomy in KNV.

Accessibility, where applicable

There is a lack of disease-specific evidence for haptonomy. Haptonomy is generally considered supplementary care, and reimbursement varies depending on the supplementary insurance plan. Discuss the goal, costs, and expectations in advance.

Sources and scientific evidence 
  • Association for Sports Medicine (VSG). VSG advice on medical specialist movement care post-COVID-19 & PAIS: recovery of physical fitness. Version 3.0. 2026. New version VSG post-COVID advice – Sports Medicine Netherlands
  • World Health Organization. Clinical management of COVID-19: living guideline. June 2025. Rehabilitation management of post-exertional symptom exacerbation.
  • KNGF. Position Paper on Physiotherapy in COVID-19: recommendations for physiotherapeutic practice in primary care. 2022. (Older document; use in conjunction with newer PAIS/PEM insights.)
  • Respiratory training effects in Long COVID-19 patients: a systematic review and meta-analysis. 2024. PMID: 38800959.
  • McNarry MA, et al. Inspiratory muscle training enhances recovery post-COVID-19: a randomized controlled trial. Eur Respir J 2022;60(4):2103101. doi:10.1183/13993003.03101-2021.
  • Törnberg A, Svensson-Raskh A, Rydwik E, et al. Effect of inspiratory muscle training on inspiratory muscle strength in adults with post-COVID-19 condition and inspiratory muscle weakness: a randomized controlled trial. J Rehabil Med. 2026;58:jrm44931. doi:10.2340/jrm.v58.44931.
  • Del Corral T, et al. Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-COVID-19: randomized controlled trial. Ann Phys Rehabil Med. 2023;66(1):101709.
  • Palau P, et al. Effect of a home-based inspiratory muscle training program on functional capacity in postdischarged patients with long COVID: the InsCOVID trial. BMJ Open Respir Res. 2022.
  • Rehabilitation in long COVID: a systematic review and meta-analysis. 2026. PMID: 42549045.
  • Li S, Dai B, Hou Y, et al. Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-analysis of randomized controlled trials. Ther Adv Respir Dis. 2025;19:17534666251323482. doi:10.1177/17534666251323482.
  • Pouliopoulou DV, Hawthorne M, MacDermid JC, et al. Prevalence and Impact of Postexertional Malaise on Recovery in Adults With Post-COVID-19 Condition: A Systematic Review With Meta-analysis. Arch Phys Med Rehabil. 2025;106(8):1267-1278. doi:10.1016/j.apmr.2025.01.471.
  • RIVM. Q fever. Modified 18 February 2026.
  • Health Council. Post-COVID. Advice No. 2026/04. 13 May 2026.
  • Romanet C, et al. Effectiveness of physiotherapy modalities on persistent dyspnoea in long COVID: a systematic review and meta-analysis. Respir Med. 2025;236:107909. doi:10.1016/j.rmed.2024.107909.
  • Post-Covid Network Netherlands. 2026. Comprehensive guidance. Accessed on 19-09-26, from Comprehensive guidance | PostCOVID Network Netherlands